• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 23 Feb 2023

    For Indian pharma, growth has got tougher with competition. But some players are rising to the task

    buy
    Pharmaceuticals & Biotech.
    by Trendlyne Analysis
    Trendlyne Analysis
    The pharmaceutical industry is a defensive sector, one that is expected to perform well even during market turmoil. Spending above a certain level remains steady, since a person’s health and medical care remains a priority irrespective of macroeconomic factors. As a result, drug makers have a beta considerably lower than 1 – their stock prices are less volatile than the overall market.
    Copy Link Share on Share on Share on Share on
    Alert  
    Axis Direct released a Sector Update report for Pharmaceuticals & Biotech. on 09 Jul, 2025.
    More from Pharmaceuticals & Biotech.
    Recommended
    Five Interesting Stocks Today - July 18, 2025
    The Baseline | 18 Jul 2025, 06:00PM
    Market closes lower, Hindustan Zinc's net profit declines 4.7% YoY in Q1FY26
    Trendlyne Marketwatch | 18 Jul 2025, 03:58PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd